Bicara Therapeutics Inc. - Common Stock (BCAX)
9.2700
-6.3900 (-40.80%)
NASDAQ · Last Trade: May 24th, 7:15 PM EDT
Bicara Therapeutics Inc. (NASDAQ: BCAX) shares are trading lower Friday following the release of updated interim data.
Via Benzinga · May 23, 2025
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · May 23, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · May 23, 2025
Via Benzinga · May 23, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · May 23, 2025
The companies are duking it out for the best treatment for head-and-neck cancer. One clearly has the edge.
Via Investor's Business Daily · May 23, 2025
Via Benzinga · May 23, 2025
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · May 23, 2025
Via Benzinga · May 16, 2025
Via Benzinga · April 17, 2025
Via Benzinga · March 25, 2025

Via Benzinga · January 17, 2025

Via Benzinga · December 9, 2024

Via Benzinga · October 8, 2024

Via Benzinga · October 8, 2024

Shares of StandardAero jumped 36% in the company's trading debut as the aircraft maintenance services provider raised $1.44 billion in its IPO. Additionally, Chain Bridge Bancorp opened on Oct. 5 at $22.
Via Talk Markets · October 6, 2024

A trio of biotech companies' shares rose on Friday in their first trading sessions. Bicara Therapeutics, MBX Biosciences, and Zenas BioPharma each sold more shares in their respective initial public offerings than they had planned.
Via Talk Markets · September 15, 2024